Facebook
Twitter
YouTube
RSS
  • Home
  • About Us
    • Who we are
    • Mission and Vision
    • Time Line
    • Advisory Council
  • Our Work
    • Prevention Policy
    • Treatment Policy
    • Human Rights
  • Publications
    • Bulletins
    • Policy Brief
  • Campaigns
  • Multimedia and Photos
    • Gallery Photos
    • Gallery Videos
  • News
  • Contact

Approval of Truvada a game changer in anti-HIV/AIDS effort

January 13, 2016

Why is the approval of Truvada for prevention so significant for Kenya? According Kenya AIDS Indicator Survey of 2012, serodiscordant couples contribute 44% of all new infections, while men who have sex with men and female sex workers contribute a third.  HIV prevalence is highest in the population 20-29 years, and young women 20-24 years are four times more likely to be HIV positive compared with young men the same age. The recent approval by the Kenya Pharmacy and Poisons Board of the drug Truvada for prevention of HIV by uninfected persons deemed at risk — pre-exposure prophylaxis (PrPEP) — reflects commitment from the regulatory authority to fast-track the review of drugs of public health importance.

Source: AVERT.

Read more here.

Categories News

Newsletter

    Your Name (required):


    Your Email (required)

    ABIA – BRAZILIAN INTERDISCIPLINARY AIDS ASSOCIATION
    GLOBAL AIDS POLICY WATCH


    Av. Presidente Vargas, 446 - 13º andar, 20071-907
    Centro - Rio de Janeiro - RJ

    +55 (21) 2223-1040


    Hivos
    Hivos
    • Home
    • About Us
      • Who we are
      • Mission and Vision
      • Time Line
      • Advisory Council
    • Our Work
      • Prevention Policy
      • Treatment Policy
      • Human Rights
    • Publications
      • Bulletins
      • Policy Brief
    • Campaigns
    • Multimedia and Photos
      • Gallery Photos
      • Gallery Videos
    • News
    • Contact